Citation Impact
Citing Papers
CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer
2017
Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer
2015
Meta-hallmarks of aging and cancer
2023
Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms
2018
Critical contribution of 3′ non-seed base pairing to the in vivo function of the evolutionarily conserved let-7a microRNA
2022 StandoutNobel
Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment
2019
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Impaired immune surveillance accelerates accumulation of senescent cells and aging
2018
Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner
2018 StandoutNobel
Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence
2015
Context-dependent effects of cellular senescence in cancer development
2016
Computationally designed sensors detect endogenous Ras activity and signaling effectors at subcellular resolution
2024 StandoutNobel
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Cancer secretome and inflammation: The bright and the dark sides of NF-κB
2017
Myeloid-derived suppressor cells coming of age
2018 Standout
Targeting cancer stem cell pathways for cancer therapy
2020
A novel albumin nanocomplex containing both small interfering RNA and gold nanorods for synergetic anticancer therapy
2015
A proteomic atlas of senescence-associated secretomes for aging biomarker development
2020 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
2016 Standout
The LIN28/let-7 Pathway in Cancer
2017
The role of myeloid cells in cancer therapies
2016
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Impact of oncogenic pathways on evasion of antitumour immune responses
2018
Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis
2016
Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation
2015
The Human Transcription Factors
2018 Standout
Neutrophils Oppose Uterine Epithelial Carcinogenesis via Debridement of Hypoxic Tumor Cells
2015
The immune contexture in cancer prognosis and treatment
2017 Standout
The ETS family of oncogenic transcription factors in solid tumours
2017
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
2017
Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells
2017
A functional genetic screen defines the AKT-induced senescence signaling network
2019
Sex differences in cancer mechanisms
2020
The tumor microenvironment
2020 Standout
The organoid-initiating cells in mouse pancreas and liver are phenotypically and functionally similar
2014
Immunosuppression associated with chronic inflammation in the tumor microenvironment
2015
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression
2016
Hitting the right spot: Mechanism of action of OPB‐31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3)
2015
Immune-mediated mechanisms influencing the efficacy of anticancer therapies
2015
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome
2020
The epigenetics of epithelial-mesenchymal plasticity in cancer
2013
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Emerging Biological Principles of Metastasis
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
EMT: 2016
2016 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Hallmarks of Cellular Senescence
2018 Standout
Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors
2014
Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy
2017
Tumor-intrinsic oncogene pathways mediating immune avoidance
2015
PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment
2022 StandoutNobel
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
2018
Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response
2019
Neutrophils in cancer: neutral no more
2016 Standout
Senescence and the SASP: many therapeutic avenues
2020
The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1
2018
Cancer-related inflammation and treatment effectiveness
2014 Standout
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
2016 StandoutNature
Metastatic colonization by circulating tumour cells
2016 StandoutNature
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Unmasking senescence: context-dependent effects of SASP in cancer
2019
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2016 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Modeling Development and Disease with Organoids
2016 Standout
A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses
2016
Prostate Cancer
2019
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Myeloid-Derived Suppressor Cells
2017
Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
2018
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
2015
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
2015
PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo
2018
Genetically Encoded Fluorescent Biosensors Illuminate the Spatiotemporal Regulation of Signaling Networks
2018
Epithelial Mesenchymal Transition in Tumor Metastasis
2018 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Senescence‐associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15
2019
The innate immune sensor Toll-like receptor 2 controls the senescence-associated secretory phenotype
2019
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Effective combinatorial immunotherapy for castration-resistant prostate cancer
2017 Nature
TISIDB: an integrated repository portal for tumor–immune system interactions
2019 Standout
JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age
2015
Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment
2016
Exosomes as Emerging Pro-Tumorigenic Mediators of the Senescence-Associated Secretory Phenotype
2019
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute
2016 StandoutNobel
Works of Sandra Pinton being referenced
Activation of the Lin28/let-7 Axis by Loss of ESE3/EHF Promotes a Tumorigenic and Stem-like Phenotype in Prostate Cancer
2016
ESE3/EHF Controls Epithelial Cell Differentiation and Its Loss Leads to Prostate Tumors with Mesenchymal and Stem-like Features
2012
RNAi-Mediated Silencing of Myc Transcription Inhibits Stem-like Cell Maintenance and Tumorigenicity in Prostate Cancer
2013
ETS Transcription Factor ESE1/ELF3 Orchestrates a Positive Feedback Loop That Constitutively Activates NF-κB and Drives Prostate Cancer Progression
2013
Enhancing Chemotherapy Efficacy in Pten-Deficient Prostate Tumors by Activating the Senescence-Associated Antitumor Immunity
2014
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer
2014 Nature
Abstract C180: Novel small molecule inhibitors of signal transducer and activator of transcription (STAT3) for cancer treatment.
2013
Split GFP technologies to structurally characterize and quantify functional biomolecular interactions of FTD-related proteins
2017